These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2884558)

  • 1. Esmolol--a short-acting i.v. beta-blocker.
    Med Lett Drugs Ther; 1987 Jun; 29(742):57-8. PubMed ID: 2884558
    [No Abstract]   [Full Text] [Related]  

  • 2. Short-acting beta-adrenergic blockade and the fetus. A case report.
    Gilson GJ; Knieriem KJ; Smith JF; Izquierdo L; Chatterjee MS; Curet LB
    J Reprod Med; 1992 Mar; 37(3):277-9. PubMed ID: 1348787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinicopharmacological studies on the bronchoconstrictive side effect of the beta-receptor blockader talinolol (Cordanum, 02-115) in patients with asthma or chronic obstructive lung diseases].
    Kandt D; Hackenberger F
    Pharmazie; 1975 Oct; 30(10):681-3. PubMed ID: 697
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term use of tobanum in arrhythmias.
    Hankóczy J; Török E; Békés M; Podmaniczky M; Cheh K
    Ther Hung; 1984; 32(1):16-8. PubMed ID: 6085943
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical trials with a new beta-sympatholytic agent].
    Beyreder J; Brandstetter G
    Wien Med Wochenschr; 1973 Feb; 123(6):76-81. PubMed ID: 4405628
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of esmolol on the hemodynamic and electrocardiographic changes during laryngomicroscopy under propofol-alfentanil anesthesia.
    Korpinen R; Simola M; Saarnivaara L
    Acta Anaesthesiol Belg; 1998; 49(2):123-32. PubMed ID: 9675382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of patient preparation with intravenous esmolol before 64-slice computed tomography coronary angiography.
    Degertekin M; Gemici G; Kaya Z; Bayrak F; Guneysu T; Sevinc D; Mutlu B; Aytaclar S
    Coron Artery Dis; 2008 Feb; 19(1):33-6. PubMed ID: 18281813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of esmolol on ST-segment depression and arrhythmias after electroconvulsive therapy.
    Zvara DA; Brooker RF; McCall WV; Foreman AS; Hewitt C; Murphy BA; Royster RL
    Convuls Ther; 1997 Sep; 13(3):165-74. PubMed ID: 9342132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-ischemia effects of gallopamil and esmolol in an intra-individual comparison in patients with coronary heart disease].
    Mitrovic V; Oehm E; Minge C; Thürmann P; Schlepper M
    Z Kardiol; 1994 Jun; 83(6):431-8. PubMed ID: 7915067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical rationale for the use of an ultra-short acting beta-blocker: esmolol.
    Barbier GH; Shettigar UR; Appunn DO
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):212-8. PubMed ID: 7620691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-arrhythmic effect of a new adrenergic beta receptor blocking substance].
    Rodrigues R; Kornfeld J; Pereira EM
    Arq Bras Cardiol; 1972 Dec; 25(6):471-5. PubMed ID: 4145022
    [No Abstract]   [Full Text] [Related]  

  • 12. [New ultra-short-acting beta-blockers: landiolol and esmolol--the effects on cardiovascular system].
    Mio Y
    Masui; 2006 Jul; 55(7):841-8. PubMed ID: 16856544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypotensive action of ICI66.082, a new beta-adrenergic blocking agent.
    Hansson L; Henningsen NC; Karlberg B; Aberg H; Jameson S; Malmcrona R; Hersvall C
    Int J Clin Pharmacol; 1974 Oct; 10(3):206-11. PubMed ID: 4154313
    [No Abstract]   [Full Text] [Related]  

  • 14. Selective beta blockade improves the outcome of cardiopulmonary resuscitation in a swine model of cardiac arrest.
    Theochari E; Xanthos T; Papadimitriou D; Demestiha T; Condilis N; Tsirikos-Karapanos N; Tsiftsi K; Papadimitriou L
    Ann Ital Chir; 2008; 79(6):409-14. PubMed ID: 19354034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The electrophysiologic properties of esmolol, a short acting beta-blocker.
    Greenspan AM; Spielman SR; Horowitz LN; Laddu A; Senior S
    Int J Clin Pharmacol Ther Toxicol; 1988 Apr; 26(4):209-16. PubMed ID: 2900217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dose-related effects of bolus esmolol on heart rate and blood pressure following laryngoscopy and intubation.
    Bensky KP; Donahue-Spencer L; Hertz GE; Anderson MT; James R
    AANA J; 2000 Oct; 68(5):437-42. PubMed ID: 11759128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of nicardipine versus esmolol in attenuating the hemodynamic responses to anesthesia emergence and extubation.
    Kovac AL; Masiongale A
    J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):45-50. PubMed ID: 17289479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic activity of esmolol (ASL-8052)--a novel ultra-short acting beta-adrenoreceptor blocking agent.
    Klein G; Wirtzfeld A; Alt E; Steck J; Saunders R; Hulse J; Kartzinel R; Lee R; Laddu AR
    Int J Clin Pharmacol Ther Toxicol; 1984 Feb; 22(2):112-7. PubMed ID: 6142005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultra-Short-Acting β-Blockers (Esmolol and Landiolol) in the Perioperative Period and in Critically Ill Patients.
    Poveda-Jaramillo R; Monaco F; Zangrillo A; Landoni G
    J Cardiothorac Vasc Anesth; 2018 Jun; 32(3):1415-1425. PubMed ID: 29398384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esmolol--just another beta blocker?
    Hall RI
    Can J Anaesth; 1992 Oct; 39(8):757-64. PubMed ID: 1363220
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.